Making Science Group S.A. (MAKS) — Capital Reinvestment Ratio
Latest as of December 2025:
0.20x
Making Science Group S.A. (MAKS) has a Capital Reinvestment Ratio of 0.20x as of December 2025, meaning it reinvests 0% of its operating cash flow (€34.10 Million) in capital expenditures (€6.97 Million). See how much free cash does Making Science Group S.A. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.20x
Capex / Operating Cash Flow
Operating Cash Flow
€34.10 Million
EUR
Capital Expenditures
€6.97 Million
EUR
Data as of
Dec 2025
Most recent filing
Making Science Group S.A. Capital Reinvestment Ratio (2020–2025)
This chart tracks Making Science Group S.A.'s Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Making Science Group S.A. (2020–2025)
Year-by-year Capital Reinvestment Ratio for Making Science Group S.A. from 2020 to 2025. For live market cap and broader valuation context, see MAKS market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | €40.25 Million | €6.97 Million | ▼ -99.0% |
| 2024 | 17.98x | €325.91K | €5.86 Million | ▲ +4120.1% |
| 2022 | 0.43x | €10.93 Million | €4.66 Million | ▼ -89.5% |
| 2021 | 4.08x | €7.21 Million | €29.40 Million | ▲ +114.6% |
| 2020 | 1.90x | €3.48 Million | €6.60 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow